Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @ASH_hematology
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @ASH_hematology
-
Germline predisposition to childhood
#leukemia: T-ALL risk variants uncovered in GWAS https://buff.ly/2vywOcR The Hematologist#leusmpic.twitter.com/L6eyX75kcI
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Access an extensive online library of
#blood disease images & cases for your projects in our Image Bank https://buff.ly/2GWFMTU#blooducationpic.twitter.com/1ID59AtM2P
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Be the first to know when registration opens for our Meeting on Lymphoma Biology by signing up for email updates https://buff.ly/35HXJQ2
#ASHMLB20pic.twitter.com/j6FM1uSsHM
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
ASH proslijedio/la je Tweet
As a result of the 2018
#sicklecell Clinical Endpoints Workshop,@ASH_hematology & @FDA_gov have unveiled new recommendations to guide clinical development in#sicklecell therapies. http://bit.ly/39bx6WH pic.twitter.com/RUHf3J38c6
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The winner of
@BloodJournal's 4th annual cover image contest is Dr. Carol La Motte et al. (issue 130-9). Blood also thanks all the authors who submitted beautiful images for their cover art. https://buff.ly/3b4EVhz pic.twitter.com/b50wOFl2tV
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Join us Wednesday, 2/5 at 1 p.m. ET for our free MEI webinar: Coaching the Problem Learner. https://buff.ly/314zta2 pic.twitter.com/abY4PLQbSu
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Complement activity and complement regulatory gene mutations are associated with
#thrombosis in APS and CAPS https://buff.ly/2RBduUQ@BloodJournalpic.twitter.com/duz1GbhzyJ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ruxolitinib for the prevention of
#thrombosis in polycythemia vera: a systematic review and meta-analysis https://buff.ly/3aXXZOL@BloodAdvancespic.twitter.com/hhwjUrWpdC
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We believe it's essential to provide updated treatment guidelines that reflect the latest evidence about
#sicklecell disease. This ensures people living with#SCD can receive better care https://www.hematology.org/SCDguidelines/ https://buff.ly/36I8sKFHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Don't miss the chance to receive $42,000 to help you gain experience in hematology research. Apply before midnight to our Physician-Scientist Career Development Award https://buff.ly/2lncZjW
#ASHAwards#ASHTraineepic.twitter.com/5j4RWRZXfL
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Read this week's issue of
@BloodJournalhttps://twitter.com/BloodJournal/status/1222957957606002689 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
ASH proslijedio/la je Tweet
Very grateful to
@ASH_hematology for the Scholar Award. It will help us understand the role of#accesstocare in pediatric#leukemia#disparities at diagnosis@UCSFChildrens. Special thanks to my incomparable mentors & advisors@slingomez@michaelseid11#ASHAwardshttps://twitter.com/UCSFCancer/status/1214346325057130497 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hurry! Apply now for the ASH Congressional Fellowship program for the chance to work closely with Congress to advance issues important to hematology. Deadline's tomorrow at 5pm ET https://buff.ly/35eVTX2
#Fight4Hematologypic.twitter.com/G46Ki6fQW3
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Missed Highlights of ASH in a state near you? Look no further, session recordings are now available for purchase! https://buff.ly/2tU6qtL
#ASHighlightspic.twitter.com/b9gDLHiPL6
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Med students & residents: Interested in a hematology career? Apply for our HONORS program & receive funding to conduct your research throughout the course of a year https://buff.ly/37Of3EV
#ASHTrainee#medstudenttwitterpic.twitter.com/0xVckfdsOB
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Are you or a colleague unsure about a clinical case? Give our Consult-A-Colleague service a go https://buff.ly/2YXnIRh pic.twitter.com/V8vLA3JAgz
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
ASH proslijedio/la je Tweet
An interview with new
@ASH_hematology president@StephanieLeeMD of@fredhutch@UWMedicine - read her story and vision for ASH in 2020 and beyond https://bit.ly/2tZtgzZ pic.twitter.com/OKX8fq8Hx0
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
.
@BloodAdvances' latest issue is now available here: http://ow.ly/DW8b50y70z7 https://twitter.com/BloodAdvances/status/1222202751620468739 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
ASH Trainees: Don’t miss this opportunity to receive $42,000 and gain research experience in the field! Apply now https://buff.ly/36xJWvF
#ASHTraineepic.twitter.com/2S2dWkXw7U
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We know gene therapy is potentially valuable to patients living with a variety of hematologic conditions, so we applaud
@US_FDA's work in the gene therapy space.https://twitter.com/SteveFDA/status/1222152149502775296 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.